Keywords: Ulcertive colitis, Market forecast, Remicade, Johnson & Johnson, P&G, Santen, Salix

Global ulcerative colitis drug market set to see “reasonable” growth to 2015

Article | 19 January 2010

According to Ulcerative Colitis - Drug Pipeline Analysis and Market Forecasts to 2015, a news report added to the offering of Research and Markets, this therapeutic sector is expected experience “reasonable” growth over the review period.

The report estimates the global ulcerative colitis market was valued at $1.3 billion in 2008. Enjoying this artcle? To continue reading you need to login, take a FREE trial or subscribe.

30 day FREE trial

Sign up in less than 60 seconds! No payment needed.

Want to read the full article?
Take a 30 day FREE Trial

Take a no obligations 30 day trial.
Only one trial per user. Find out more details

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in